Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was incorporated in 1989 and is based in Gothenburg, Sweden.
Metrics to compare | VITR | Peers Peers - average of corresponding metrics from companies closely matching VITR: NTRA, BIOGB, PROB, CRNOSb_old, DEX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipVITRPeersSector |
---|---|---|---|---|
P/E Ratio | −7.3x | −1.0x | −0.7x | |
PEG Ratio | 0.01 | −0.02 | 0.00 | |
Price/Book | 2.1x | 2.4x | 2.6x | |
Price / LTM Sales | 7.8x | 6.2x | 3.1x | |
Upside (Analyst Target) | 29.8% | 120.9% | 55.4% | |
Fair Value Upside | Unlock | 26.8% | 9.9% | Unlock |